DESIGN, PREPARE AND IN VITRO EVALUATION OF NERATINIB LOADED ETHOSOMAL GEL

The present study aimed to formulate and evaluate a Neratinib-loaded ethosomal gel as a novel topical drug delivery system to enhance drug permeation, improve sustained release, and increase therapeutic efficacy. Eight Neratinib-loaded ethosomal formulations (F1–F8) were prepared using varying concentrations of phosphatidylcholine and subsequently incorporated into Carbopol 934 gel. The prepared formulations were evaluated for vesicle size, zeta potential, surface morphology, pH, viscosity, spreadability, entrapment efficiency, in vitro drug release, release kinetics, and stability. The ethosomal vesicles exhibited particle sizes ranging from 180 to 201 nm with zeta potential values between −22 and −28 mV, indicating nanosized, physically stable vesicles. SEM analysis confirmed spherical, smooth, and uniformly distributed ethosomes. Among all the formulations, F8 was identified as the optimized formulation, exhibiting the highest drug entrapment efficiency (96.32%), suitable viscosity (7258 cps), excellent spreadability (26.25 g·cm/sec), and maximum cumulative drug release of 99.12% over 12 hours. Drug release kinetic analysis revealed that the optimized formulation followed the Higuchi diffusion model (R² = 0.993), indicating diffusion-controlled sustained drug release. Accelerated stability studies conducted for three months demonstrated that the optimized formulation remained physically stable with no significant changes in drug content or formulation characteristics. The results of the present investigation indicate that Neratinib-loaded ethosomal gel is a promising topical drug delivery system capable of providing sustained drug release, enhanced stability, and improved drug permeation. This formulation has the potential to improve localized therapeutic efficacy while minimizing systemic side effects. Keywords: Neratinib, Phosphatidylcholine, Cold method, Ethosomes, Carbopol 934, In vitro drug release studies

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24403828
Primary Topic
Advancements in Transdermal Drug Delivery
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

DESIGN, PREPARE AND IN VITRO EVALUATION OF NERATINIB LOADED ETHOSOMAL GEL

Reddy Nazemoon*, G . Pravalika
3 links
Zenodo (CERN European Organization for Nuclear Research)
Advancements in Transdermal Drug Delivery
preprint

DESIGN, PREPARE AND IN VITRO EVALUATION OF NERATINIB LOADED ETHOSOMAL GEL

Reddy Nazemoon*, G . Pravalika
preprint en

Abstract

The present study aimed to formulate and evaluate a Neratinib-loaded ethosomal gel as a novel topical drug delivery system to enhance drug permeation, improve sustained release, and increase therapeutic efficacy. Eight Neratinib-loaded ethosomal formulations (F1–F8) were prepared using varying concentrations of phosphatidylcholine and subsequently incorporated into Carbopol 934 gel. The prepared formulations were evaluated for vesicle size, zeta potential, surface morphology, pH, viscosity, spreadability, entrapment efficiency, in vitro drug release, release kinetics, and stability. The ethosomal vesicles exhibited particle sizes ranging from 180 to 201 nm with zeta potential values between −22 and −28 mV, indicating nanosized, physically stable vesicles. SEM analysis confirmed spherical, smooth, and uniformly distributed ethosomes. Among all the formulations, F8 was identified as the optimized formulation, exhibiting the highest drug entrapment efficiency (96.32%), suitable viscosity (7258 cps), excellent spreadability (26.25 g·cm/sec), and maximum cumulative drug release of 99.12% over 12 hours. Drug release kinetic analysis revealed that the optimized formulation followed the Higuchi diffusion model (R² = 0.993), indicating diffusion-controlled sustained drug release. Accelerated stability studies conducted for three months demonstrated that the optimized formulation remained physically stable with no significant changes in drug content or formulation characteristics. The results of the present investigation indicate that Neratinib-loaded ethosomal gel is a promising topical drug delivery system capable of providing sustained drug release, enhanced stability, and improved drug permeation. This formulation has the potential to improve localized therapeutic efficacy while minimizing systemic side effects. Keywords: Neratinib, Phosphatidylcholine, Cold method, Ethosomes, Carbopol 934, In vitro drug release studies

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon